United Therapeutics Stock
United Therapeutics Stock
A very strong showing by United Therapeutics today, with an increase of €21.70 (9.880%) compared to yesterday's price.
United Therapeutics is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 288 € shows a slightly positive potential of 19.3% compared to the current price of 241.4 € for United Therapeutics.
Pros and Cons of United Therapeutics in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 9.880% | 0.274% | 3.242% | 5.120% | 10.820% | 29.235% | 140.873% |
| Ironwood Pharmaceuticals | 0.690% | -2.685% | -8.228% | -22.872% | -28.922% | -21.622% | - |
| Sage Therapeutics Inc. | -3.520% | 7.851% | -25.000% | -69.792% | -34.750% | -79.867% | - |
| Novocure Ltd | 8.240% | 1.864% | -20.671% | -80.817% | -19.615% | -93.244% | - |
Comments
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for UTHR provided by MarketBeat